Outcomes of Medicare Beneficiaries With Heart Failure and Atrial Fibrillation

被引:59
|
作者
Khazanie, Prateeti [1 ,2 ]
Liang, Li [1 ]
Qualls, Laura G. [1 ]
Curtis, Lesley H. [1 ,2 ]
Fonarow, Gregg C. [3 ]
Hammill, Bradley G. [1 ,4 ]
Hammill, Stephen C.
Heidenreich, Paul A. [5 ]
Masoudi, Frederick A. [6 ]
Hernandez, Adrian F. [1 ,2 ]
Piccini, Jonathan P. [1 ,2 ]
机构
[1] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[2] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[3] Ahmanson UCLA Cardiomyopathy Ctr, Los Angeles, CA USA
[4] Mayo Clin, Rochester, MN USA
[5] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
[6] Univ Colorado, Aurora, CO USA
基金
美国医疗保健研究与质量局;
关键词
atrial fibrillation; heart failure; Medicare; mortality outcome; assessment (health care); patient readmission; VENTRICULAR SYSTOLIC DYSFUNCTION; PROFILING HOSPITAL PERFORMANCE; OPTIMIZE-HF; MORTALITY; RISK; REGISTRY; STROKE; READMISSION; RIVAROXABAN; PROGRESSION;
D O I
10.1016/j.jchf.2013.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives This study sought to examine the long-term outcomes of patients hospitalized with heart failure and atrial fibrillation. Background Atrial fibrillation is common among patients hospitalized with heart failure. Associations of pre-existing and new-onset atrial fibrillation with long-term outcomes are unclear. Methods We analyzed 27,829 heart failure admissions between 2006 and 2008 at 281 hospitals in the American Heart Association's Get With The Guidelines-Heart Failure program linked with Medicare claims. Patients were classified as having pre-existing, new-onset, or no atrial fibrillation. Cox proportional hazards models were used to identify factors that were independently associated with all-cause mortality, all-cause readmission, and readmission for heart failure, stroke, and other cardiovascular disease at 1 and 3 years. Results After multivariable adjustment, pre-existing atrial fibrillation was associated with greater 3-year risks of all-cause mortality (hazard ratio [HR]: 1.14 [99% confidence interval (CI): 1.08 to 1.20]), all-cause readmission (HR: 1.09 [99% CI: 1.05 to 1.14]), heart failure readmission (HR: 1.15 [99% CI: 1.08 to 1.21]), and stroke readmission (HR: 1.20 [99% CI: 1.01 to 1.41]), compared with no atrial fibrillation. There was also a greater hazard of mortality at 1 year among patients with new-onset atrial fibrillation (HR: 1.12 [99% CI: 1.01 to 1.24]). Compared with no atrial fibrillation, newonset atrial fibrillation was not associated with a greater risk of the readmission outcomes. Stroke readmission rates at 1 year were just as high for patients with preserved ejection fraction as for patients with reduced ejection fraction. Conclusions Both pre-existing and new-onset atrial fibrillation were associated with greater long-term mortality among older patients with heart failure. Pre-existing atrial fibrillation was associated with greater risk of readmission. (C) 2014 by the American College of Cardiology Foundation
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [21] Atrial Fibrillation Ablation Outcomes and Heart Failure (from the Kansai Plus Atrial Fibrillation Registry)
    Tanaka, Nobuaki
    Inoue, Koichi
    Kobori, Atsushi
    Kaitani, Kazuaki
    Morimoto, Takeshi
    Kurotobi, Toshiya
    Morishima, Itsuro
    Yamaji, Hirosuke
    Matsui, Yumie
    Nakazawa, Yuko
    Kusano, Kengo
    Tanaka, Koji
    Hirao, Yuko
    Okada, Masato
    Koyama, Yasushi
    Okamura, Atsunori
    Iwakura, Katsuomi
    Fujii, Kenshi
    Kimura, Takeshi
    Shizuta, Satoshi
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 189 : 108 - 118
  • [22] Atrial Fibrillation Ablation Outcomes and Heart Failure (from the Kansai Plus Atrial Fibrillation Registry)
    Tanaka, Nobuaki
    Inoue, Koichi
    Kobori, Atsushi
    Kaitani, Kazuaki
    Morimoto, Takeshi
    Kurotobi, Toshiya
    Morishima, Itsuro
    Yamaji, Hirosuke
    Matsui, Yumie
    Nakazawa, Yuko
    Kusano, Kengo
    Tanaka, Koji
    Hirao, Yuko
    Okada, Masato
    Koyama, Yasushi
    Okamura, Atsunori
    Iwakura, Katsuomi
    Fujii, Kenshi
    Kimura, Takeshi
    Shizuta, Satoshi
    KPAF Investigators
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 189 : 1 - 11
  • [23] Predicting Costs Among Medicare Beneficiaries With Heart Failure
    Greiner, Melissa A.
    Hammill, Bradley G.
    Fonarow, Gregg C.
    Whellan, David J.
    Eapen, Zubin J.
    Hernandez, Adrian F.
    Curtis, Lesley H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (05): : 705 - 711
  • [24] Economic burden of hospitalizations of Medicare beneficiaries with heart failure
    Kilgore, Meredith
    Patel, Harshali K.
    Kielhorn, Adrian
    Maya, Juan F.
    Sharma, Pradeep
    RISK MANAGEMENT AND HEALTHCARE POLICY, 2017, 10 : 63 - 70
  • [25] Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries
    Ellis, Ethan R.
    Culler, Steven D.
    Simon, April W.
    Reynolds, Matthew R.
    HEART RHYTHM, 2009, 6 (09) : 1267 - 1273
  • [26] ARE MEDICARE BENEFICIARIES WITH HEART FAILURE RECEIVING RECOMMENDED TREATMENT?
    Dutcher, S. K.
    Zuckerman, I. H.
    Rattinger, G. B.
    Chhabra, P. T.
    Gottlieb, S. S.
    Simoni-Wastila, L.
    Stuart, B.
    GERONTOLOGIST, 2011, 51 : 9 - 9
  • [27] Heart failure and atrial fibrillation: Is atrial fibrillation ablation in heart failure pointless or mandatory?
    Kantharia, Bharat K.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2024, 35 (03) : 530 - 537
  • [28] Atrial fibrillation and heart failure: Is atrial fibrillation a disease?
    Tilman, V.
    MEDICAL HYPOTHESES, 2014, 83 (03) : 299 - 301
  • [29] Heart failure and cardiovascular outcomes in european patients with atrial fibrillation
    Bonini, N.
    Proietti, M.
    Romiti, G. F.
    Vitolo, M.
    Fawzy, A. M.
    Ding, Y. D.
    Fauchier, L.
    Marin, F.
    Nabauer, M.
    Potpara, T. S.
    Dan, G. -A.
    Boriani, G.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2316 - 2316
  • [30] Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation
    Tersalvi, Gregorio
    Bossard, Matthias
    Aeschbacher, Stefanie
    Wiencierz, Andrea
    Beer, Jurg H.
    Rodondi, Nicolas
    Gencer, Baris F.
    Reichlin, Tobias
    Auricchio, Angelo
    Ammann, Peter
    Moschovitis, Giorgio
    Bonati, Leo
    Osswald, Stefan
    Kuehne, Michael
    Conen, David
    Kobza, Richard
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 412